These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 3636325

  • 1. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G, Peters G, Kunstmann G.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B, Hall I.
    Curr Med Res Opin; 1984 May; 9(3):157-60. PubMed ID: 6568146
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L, Verhaegen J.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [Abstract] [Full Text] [Related]

  • 4. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D, Le Noc P, Robert J.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ, Prior RB.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [Abstract] [Full Text] [Related]

  • 6. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G, Dorche G, Frere A, Raby N, Denis M.
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
    Sparks SE, Jones RL, Kilgore WR.
    Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
    [Abstract] [Full Text] [Related]

  • 8. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [Abstract] [Full Text] [Related]

  • 9. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR, Chang SC, Chen YC, Hsu LY, Luh KT, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C, Amsterdam D, Beam T, Gorzynski E.
    Diagn Microbiol Infect Dis; 1989 Aug; 12(2):157-63. PubMed ID: 2752713
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R, Beale AS, Boon RJ, Griffin KE, Slocombe B, Stokes DH, White AR.
    Am J Med; 1985 Nov 29; 79(5B):13-24. PubMed ID: 3878080
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P, Glauser M.
    Eur J Clin Microbiol; 1983 Dec 29; 2(6):541-7. PubMed ID: 6607834
    [Abstract] [Full Text] [Related]

  • 13. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr 29; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 14. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
    Gould IM, Dent J, Wise R.
    J Antimicrob Chemother; 1987 Mar 29; 19(3):307-12. PubMed ID: 3106304
    [Abstract] [Full Text] [Related]

  • 15. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
    Paisley JW, Washington JA.
    Antimicrob Agents Chemother; 1978 Aug 29; 14(2):224-7. PubMed ID: 308792
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC, Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1984 Mar 29; 25(3):392-4. PubMed ID: 6721472
    [Abstract] [Full Text] [Related]

  • 17. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM, Lamothe F.
    J Antimicrob Chemother; 1986 May 29; 17(5):593-603. PubMed ID: 3636324
    [Abstract] [Full Text] [Related]

  • 18. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
    Stobberingh EE.
    J Antimicrob Chemother; 1988 Jan 29; 21(1):9-16. PubMed ID: 3128523
    [Abstract] [Full Text] [Related]

  • 19. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ, Beale AS, Sutherland R.
    Antimicrob Agents Chemother; 1986 May 29; 29(5):838-44. PubMed ID: 3524431
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 May 29; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.